Orchid Pharma Ltd - 524372 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhanuka Laboratories Ltd Orchid Pharma OFS fully subscribed
The offer-for-sale in Orchid Pharma by its promoter received strong response from both non-institutional (HNI) and retail investors. While the HNI por
Nureca shares locked in 5% upper circuit after Hornbill Orchid India buys 2% stake
Hornbill Orchid India Fund, a Mauritius-based hedge fund, acquired a 1.95 percent equity stake in Nureca, a home healthcare and wellness products seller. Orchid Pharma Ltd - 524372 - Notice of Offer for Sale of Shares by Promoter & Floor Price
Notice for the proposed offer for sale ("Notice") of the equity shares of face value of Rs. 10 each ("Equity Shares") of Orchid Pharma Ltd ("Orchid / Company") by Dhanuka Laboratories Limited ("Seller"), being the promoter of the Company. Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 23(9) Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations,2015 For The Half Year Ended March 31,2021
Disclosure under Regulation 23(9) of the SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015 for the half year ended March 31,2021 Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-Investor presentation Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of The SEBI(LODR) Regulations,2015-Approval For Reclassification Of Shareholders Of Orchid Pharma Limited ('The Company') From The 'Promoter And Promoter Group' Category To 'Public' Category Under Regulation 31A Of The Listing Regulation
Disclosure under Regulation 30 of the SEBI(LODR) Regulations,2015-Approval for Reclassification of Shareholders of Orchid Pharma Limited ('the Company') from the 'Promoter and Promoter Group' category to 'Public' category under Regulation 31A of the SEBI(LODR) Regulations,2015 Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015- Investor Presentation Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation
Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015-Investor Presentation Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 30 Of The SEBI(LODR) Regulations,2015
Disclosure under Regulation 30 of the SEBI(LODR) Regulations,2015